Results 1 to 10 of about 14,384 (192)

Blood Glial Fibrillary Acidic Protein in MRI‐Negative Attack‐Like Episodes of Neuromyelitis Optica Spectrum Disorder [PDF]

Eur J Neurol
ABSTRACT Objectives Magnetic resonance imaging (MRI) is widely used to support relapse diagnosis in neuromyelitis optica spectrum disorder (NMOSD), yet some patients present with attack‐like symptoms without corresponding lesions. We assessed serum glial fibrillary acidic protein (sGFAP) levels in MRI‐negative attack‐like episodes.
Kim S, Chung J, Payumo R, Hyun J, Kim H.
europepmc   +2 more sources

Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic Review. [PDF]

Neurol Neuroimmunol Neuroinflamm
Musubire AK, Derdelinckx J, Reynders T, Meya DB, Bohjanen PR, Cras P, Willekens B.   +6 more
europepmc   +1 more source

Immunity Gone Viral: Subacute Cognitive Decline With Multifocal Brain Lesions in Neuromyelitis Optica Spectrum Disorder. [PDF]

Neurol Neuroimmunol Neuroinflamm
Ajwani S, Weinshenker BG, Giannini C, Habermann TM, Wang Y, Skrabek P, Balusha A, Toledano M, Horsman SE, Lucchinetti CF, Flanagan EP.   +10 more
europepmc   +1 more source

Quality of life and its influencing factors in patients with neuromyelitis optica spectrum disorder. [PDF]

Front Neurol
Lei ZY, Li HP, Yang Q, Zhang XP, Wang LX, Liu ZY.   +5 more
europepmc   +1 more source

Neuromyelitis optica spectrum disorder associated with cutaneous lupus and multidrug immunosuppressant hypersensitivity. [PDF]

BMJ Case Rep
Chu Han C, Shahidatul-Adha M, Wan Hitam WH.   +2 more
europepmc   +1 more source

The role of neuroimmunology subspecialty in disease management of patients with neuromyelitis optica spectrum disorder. [PDF]

Orphanet J Rare Dis
Xue B, Li J, Xie D, Zhang X, Xia J, Li X, Lin J.   +6 more
europepmc   +1 more source

Functional and effective connectivity alterations relate to cognitive performance in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder. [PDF]

Brain Commun
Leveraro E, Cipriano E, Lombardi G, Currò D, Tazza F, Novi G, Laroni A, Gazzola P, Malentacchi M, Petrucci L, Lapucci C, Inglese M.   +11 more
europepmc   +1 more source

Ferritin-ApoE nanocarrier for targeted therapy of neuromyelitis optica spectrum disorder in mice. [PDF]

J Neuroinflammation
Zhao X, Liang Q, Lin K, Jiang S, Yang T, Sun M, Song R, Yan J, Palma-Tortosa S, Kokaia Z, Yan X, Du G, Fan K, Jin WN.   +13 more
europepmc   +1 more source

Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disorders. [PDF]

Neurol Res Pract
Tkachenko D, Ayzenberg I, Schöppe LM, Schülke R, Paul F, Duchow A, Bellmann-Strobl J, Siebert N, Kümpfel T, Havla J, Pellkofer H, Jarius S, Wildemann B, Berthele A, Klotz L, Pawlitzki M, Gingele S, Schreiber-Katz O, Weber MS, Senel M, Stellmann JP, Häußler V, Aktas O, Ringelstein M, Hellwig K, Schwake C, Kleiter I, Trebst C, Hümmert MW, Neuromyelitis Optica Study Group (NEMOS)§.   +29 more
europepmc   +1 more source

The IL-1β-STING Signaling Axis Drives Neuromyelitis Optica Pathogenesis in a Murine Model. [PDF]

Ann Neurol
Han S, Liang Z, Zhang C, Yang S, Li J, Jiang W, Xu H, Li H, Xiang X, Guo R, Luo W, Li B, Tang C, Zhang Y, Yang S, Wang G.   +15 more
europepmc   +1 more source